About Execupharm
Execupharm is a company based in King Of Prussia (United States) founded in 2009 was acquired by Parexel in September 2016. Execupharm operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
- Headquarter King Of Prussia, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Execupharm
Detailed funding history for Execupharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Execupharm
Execupharm has secured backing from 1 investor. Prominent investors backing the company include Parexel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Full-service clinical research organization services are provided globally by Parexel.
|
Locked | Locked | Locked |
Investor details for Execupharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Execupharm
Investment portfolio details for Execupharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Execupharm
Detailed financials for Execupharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Execupharm Comparisons
Peer comparison for Execupharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Execupharm
Execupharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Clinical trials and regulatory submissions are supported as a CRO.
|
|
| Locked | Locked | Locked |
CRO focused on data management, regulatory affairs and consulting services
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
Detailed competitors of Execupharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Execupharm
Complete news archive for Execupharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Execupharm
Execupharm was founded in 2009.
Execupharm is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Execupharmas three major offerings include CRO support services, functional and cross-functional resourcing outsourcing and traditional resourcing services to its pharma and biotech clients. Its CRO support services include clinical trial management, monitoring and site management, clinical trial administration, document management, contract and grants management, medical writing, regulatory, and vendor oversight services. The company also provides functional and cross-functional resourcing and outsourcing services, that mainly offer qualified professionals across a specific functional area, along with associated operational services to clients. Under traditional resourcing, it offers its clients with Specific, Qualified Professionals who can end up as permanent employees or as contingent workers. The company was created in 1995 as a global resourcing firm for clients in the pharmaceutical, biotech and medical device industry. It currently has operations in US, Canada, Mexico, Argentina, UK, India, China and Japan. It was acquired by Parexel in September, 2016.
Execupharm's top competitors include Emmes, Syneos Health and ClinChoice.
Execupharm has 1 investor. Key investors include Parexel.